a list of the National Cancer Institute's  Comprehensive Cancer Centers) and the CIBMTR data.
Monthly counts of the number of women undergoing HDC/HCT and reported to the CIBMTR registry are displayed in Figure 1.
The main limitation of this study is that we cannot observe abandonment patterns at hospitals and cancer clinics that did not report data to the CIBMTR registry.
The CIBMTR is supported by Public Health Service Grant/Cooperative Agreement U24-CA76518 from the National Cancer Institute (NCI), the National Heart, Lung and Blood Institute (NHLBI), and the National Institute of Allergy and Infectious Diseases (NIAID); a Grant/Cooperative Agreement 5U01HL069294 from NHLBI and NCI; a contract HHSH234200637015C with Health Resources and Services Administration (HRSA/DHHS); two grants N00014-06-1-0704 and N00014-08-1-0058 from the Office of Naval Research; and grants from AABB; Allos Inc.
is a combined research program of the Medical College of Wisconsin and the National Marrow Donor Program.
Matthew Gress, ComprehensiveBMT product manager, adds, "RemedyMD worked closely with the CIBMTR
when building the forms included with the product, and we're very happy with the end result.
The funding, awarded NIH "Roadmap Re-Engineering the Clinical Research Enterprise," will support doctors and information specialists from the NMDP in Minneapolis and the CIBMTR in Milwaukee to develop a public system for electronic exchange of clinical network transplantation data.
NMDP and CIBMTR said in the press release that the effort is intended to result in:
This contract demonstrates the synchronization achieved when the NMDP and the International Bone Marrow Transplant Registry (IBMTR) combined their research efforts to create the CIBMTR," said Mary Horowitz, MD, scientific director of CIBMTR and co-principal investigator of the project.
Figure 6: Annual number of hematopoietic stem cell transplantations worldwide, 1970-2006, according to CIBMTR data 14
Figure 7: Stem cell sources for allogeneic and autologous transplants in patients over 20 years of age, 1997-2006, according to CIBMTR data 19
Figure 8: The use of myeloablative and reduced-intensity conditioning regimens in allogeneic transplants, 1998-2006 according to CIBMTR data 26